Accelerated skin aging is a side effect of GLP-1 medications, but experts say there are products that can help ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

The surrounding buzz is deafening, fuelled by incredible claims of effortless weight loss. But while Berberine, or Daru Haldi ...

There in my bedroom, in the middle of the night, I saw my 11-year-old daughter clutching her ribs in agony. In the mad dash to hospital, I tried to stay calm, but I was full of fear and ...

"I don't want to see a resurgence of women destroying their bodies to get thin," Kaila Uli, 33, told Newsweek.

Even with fewer cylinders, the new 2026 Bentayga Speed has plenty to like by HANNAH ELLIOTT SOME people get hung up counting ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the future.

For Immediate Release Chicago, IL – July 10, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog.

When the narcissistic gang from "It’s Always Sunny in Philadelphia" visited the "Abbott Elementary" school in a crossover ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Novo Nordisk A/S (NVO) ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.